BTAI
Price
$0.34
Change
-$0.01 (-2.86%)
Updated
Jan 17 closing price
Capitalization
17.07M
47 days until earnings call
JSPR
Price
$5.51
Change
+$0.17 (+3.18%)
Updated
Jan 17 closing price
Capitalization
82.66M
Ad is loading...

BTAI vs JSPR

Header iconBTAI vs JSPR Comparison
Open Charts BTAI vs JSPRBanner chart's image
BioXcel Therapeutics
Price$0.34
Change-$0.01 (-2.86%)
Volume$896.02K
Capitalization17.07M
Jasper Therapeutics
Price$5.51
Change+$0.17 (+3.18%)
Volume$722.12K
Capitalization82.66M
BTAI vs JSPR Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. JSPR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and JSPR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BTAI: $0.34 vs. JSPR: $5.51)
Brand notoriety: BTAI and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 86% vs. JSPR: 143%
Market capitalization -- BTAI: $17.07M vs. JSPR: $82.66M
BTAI [@Biotechnology] is valued at $17.07M. JSPR’s [@Biotechnology] market capitalization is $82.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 3 TA indicator(s) are bullish while JSPR’s TA Score has 4 bullish TA indicator(s).

  • BTAI’s TA Score: 3 bullish, 6 bearish.
  • JSPR’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, both BTAI and JSPR are a bad buy in the short-term.

Price Growth

BTAI (@Biotechnology) experienced а -8.83% price change this week, while JSPR (@Biotechnology) price change was -21.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

JSPR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($82.7M) has a higher market cap than BTAI($17.1M). BTAI YTD gains are higher at: -7.997 vs. JSPR (-74.228). BTAI has higher annual earnings (EBITDA): -56.15M vs. JSPR (-67.27M). JSPR has more cash in the bank: 92.5M vs. BTAI (40.4M). JSPR has less debt than BTAI: JSPR (2.07M) vs BTAI (105M). BTAI has higher revenues than JSPR: BTAI (2.28M) vs JSPR (0).
BTAIJSPRBTAI / JSPR
Capitalization17.1M82.7M21%
EBITDA-56.15M-67.27M83%
Gain YTD-7.997-74.22811%
P/E RatioN/AN/A-
Revenue2.28M0-
Total Cash40.4M92.5M44%
Total Debt105M2.07M5,075%
FUNDAMENTALS RATINGS
BTAI: Fundamental Ratings
BTAI
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BTAIJSPR
RSI
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 5 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
55%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
65%
MACD
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
68%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 27 days ago
70%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
60%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
75%
View a ticker or compare two or three
Ad is loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with SYBX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-0.52%
SYBX - BTAI
39%
Loosely correlated
+0.69%
SBHMY - BTAI
32%
Poorly correlated
N/A
COGT - BTAI
31%
Poorly correlated
-1.23%
CRMD - BTAI
29%
Poorly correlated
-4.85%
JSPR - BTAI
29%
Poorly correlated
+3.18%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with OMGA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then OMGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+3.18%
OMGA - JSPR
43%
Loosely correlated
-3.04%
AVXL - JSPR
34%
Loosely correlated
-9.26%
UBX - JSPR
34%
Loosely correlated
+2.37%
IMNM - JSPR
31%
Poorly correlated
+1.32%
ATXI - JSPR
30%
Poorly correlated
+5.71%
More